Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT00213876
First received: September 13, 2005
Last updated: August 29, 2011
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Estimated Primary Completion Date: No date given